Investor · 2 deals
Every published round IGNITE took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| OncoRes Medical | Accelerator | 29 Oct 2020 | - | Lead | Brandon Capital portfolio (Thu 29 Oct 2020), Startup News (WA), Brandon Capital portfolio (Wed 22 Jul 2020), Brandon BioCatalyst portfolio | |
| OncoRes Medical | Grant | 29 Jul 2020 | $10k | Participant | Brandon Capital portfolio (Thu 29 Oct 2020), Startup News (WA), Brandon Capital portfolio (Wed 22 Jul 2020), Brandon BioCatalyst portfolio |
Everyone IGNITE has named to a program in published coverage. A place in a program is not a raise: the cheque is the figure recorded with the place, which is the program's standard terms where we hold them, and a blank is one we don't.
Companies IGNITE has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| OncoRes Medical | 29 Jul 2020, Grant | 2 | 1 |
Fund closes reported for IGNITE, as distinct from the investments it has made.
Companies IGNITE has backed that another company then bought. An exit for the holding, not a deal IGNITE did.
Stories naming IGNITE. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Perth medtech OncoRes Medical won the IGNITE Madness 2020 pitch competition in Houston, earning a US$10,000 cash prize plus a Texas Medical Centre Ventures investment prize valued above US$100,000.